Lynne M Quittell, MD - ColumbiaDoctors

Photos

15 N Broadway Ste N
White Plains, NY 10601
Dr. Quittell is a Special Lecturer in the Pediatric Pulmonary Division. She is the former Director of the Cystic Fibrosis Center and has served on multiple national committees including the ATS Planning Committee and the Cystic Fibrosis Center Director's Committee. She is the Associate Director of the Data Safety Monitoring Board for the CF Foundation. Dr. Quittell has participated in the development of new treatment guidelines for the Cystic Fibrosis community and is actively involved in clinical research. The Cystic Fibrosis Center provides multidisciplinary care for the treatment of Cystic Fibrosis including participation in clinical trials for novel therapies.
Owner verified
See a problem?

You might also like

Aviva B. Sopher, MD, MS
Internal medicine practitioners, Respiratory health clinic

Aviva B. Sopher, MD, MS

I am a pediatric endocrinologist with interests that include polycysytic ovary syndrome (PCOS), bone health, disorders of puberty, thyroid disorders, pituitary disorders and growth disorders. In addition to my training in pediatrics and pediatric endocrinology, I have Master of Science degrees in Nutrition (1999) and in Patient Oriented Research (2014) and have completed a research fellowship at the Body Composition Unit of Columbia University Medical Center (2003). I comleted the TRANSFORM KL2 program sponsored by the Irving Institute of Clinical and Translational Research, a mentored career development program. My responsibilites include my clinical practice, overseeing clinical and research fellows, mentoring students, and running a clinical study. I have been certified as a clinical densitometrist by the International Society of Clinical Densitometry and interpret pediatric bone mineral density studies performed at Columbia University Irving Medical Center. My research project, “A double-blind placebo-controlled randomized clinical trial assessing the efficacy of metformin for hepatic fat in adolescents and young adults with polycystic ovary syndrome” has the primary goal of exploring the use of novel and noninvasive testing and a pilot double-blind placebo-controlled trial of metformin with the intention of identifying and potentially treating non-alcoholic fatty liver disease in adolescents and young adults with PCOS. My research is unique in that it uses minimally invasive body composition methodology, which makes it particularly attractive for use in adolescents and young adults. My overall clinical research goal is early identification and treatment of metabolic and body composition abnormalities associated with PCOS and to prevent lifelong morbidity associated with this disorder in a young population
United StatesNew YorkWhite PlainsLynne M Quittell, MD - ColumbiaDoctors

Partial Data by Infogroup (c) 2025. All rights reserved.

Partial Data by Foursquare.